PG- Dr DevangiJoshi
SR- Dr Shipra
Consultant- Dr Shikha Jain
2.
§ 69 years,Male
§ A resident of Haryana
§ A retired govt officer by profession
3.
§ The patientpresented with complaints of diminution of vision and
foreign body sensation in his right eye since 1.5 months at the time
of presentation
4.
§ The patientwas apparently well 1.5 months ago when he started
experiencing:
§ Diminution of vision
§ In his right eye
§ Painless
§ Gradual in onset
§ Progressively increasing over time
§ Foreign body sensation in his right eye
5.
§ No historyof similar complaints in the past
§ No h/o redness, itching, or increased watering from the eyes
§ No h/o discharge from the eyes
§ No h/o trauma/ foreign body injury to the eye
6.
§ H/o presbyopicspectacle use since 15 years
§ No similar complaints in the past
§ No h/o systemic/ immunocompromised illness in the past
§ No h/o any blood transfusions in the past
§ No h/o any surgical intervention in the past
§ No h/o any topical/systemic drug use
7.
§ Non-vegetarian bydiet
§ Normal sleep and appetite
§ Normal bowel and bladder habits
§ H/o beedi smoking + since 40-50 years (6-8 beedis per day)
§ No h/o alcohol consumption
§ No h/o multiple sexual partners in the past
§ Average built
§Was conscious, well oriented to time, place, person
§ PR: 74/min
§ BP: 134/82 mmHg in right arm, sitting position
§ No pallor, icterus, cyanosis, clubbing, lymphadenopathy
10.
RE LE
VISUAL ACUITYAIDED 6/36 6/9
COLOR VISION Normal Normal
HEAD POSTURE Straight with no face turn,
chin lift, head tilt
FACIAL SYMMETRY Maintained Maintained
EOM Full and free in all gazes Full and free in all gazes
11.
RE LE
EYELIDS AND
ADNEXA
Normallid position , movements , lid margin,
eyelashes and skin of eyelids
Normal lid position, movements, lid margin,
eyelashes and skin of eyelids
LACRIMAL
APPARATUS
Normal puncta, lacrimal sac area , patent
nasolacrimal duct on syringing
Normal puncta, lacrimal sac area , patent
nasolacrimal duct on syringing
CONJUNCTIVA Normal palpebral conjunctiva and fornices
Mild palpebral congestion + (temporal> nasal)
Early pinguecula formation in temporal region
Normal bulbar conjunctiva
palpebral conjunctiva and fornices
SCLERA Normal with no discoloration , dilated vessels
and any other abnormalities
Normal with no discoloration , dilated vessels
and any other abnormalities
12.
CORNEA Normal shapeand size with corneal sensations
intact
Spheroidal degeneration + at nasal and temporal
areas near the limbus
Transparent, lustrous, avascular with normal
shape, size and corneal sensation intact
EXAMINATION
• Location: 8-9 o’clock position temporally near the limbus
• Multifocal and Patchy involving 2.5 mm x 0.5 mm area
• Yellowish brown in colour
• Form- Sessile, nodular and raised with well-defined margins
• Feeder vessels +
• Fixed to the underlying structure, no intralesional cysts, no ulceration
• Corneal involvement + (patchy and multifocal, whitish in colour, involving till epithelium layer on
slit lamp examination, with no feeder vessels)
• No signs of lymphadenopathy
RE LE
ANTERIOR
CHAMBER
VH gd4, no cells, flare pigmentations VH gd 4, no cells, flare pigmentations
IRIS AND PUPIL Normal colour and radial pattern
3mm in size, round in shape, one in number
normal reaction with direct light and swinging
light
Normal colour and radial pattern
3mm size, round shape, one in number, normal
reaction with direct light and swinging light
LENS Phakic , biconvex shape, transparent Phakic , biconvex shape, transparent
Fundus examination Red glow +
Media clear
Disc margins well defined
C:D Ratio- 0.3:1
A:V – 2:3
FR +
Periphery WNL
Red glow +
Media clear
Disc margins well defined
C:D Ratio- 0.3:1
A:V – 2:3
FR +
Periphery WNL
IOP (GAT) 12 mmHg 12mmHg
15.
§ Impression Cytology-smear showed very scant cellularity revealing very
occasional mature squamous cells and anucleated squamous cells
§ Right eyeOSSN with corneal involvement with preexisting spheroidal
degeneration of cornea
18.
§ Topical chemotherapy:
§5- Fluorouracil (5- FU)- 1 cycle is 4 times a day for 1 week followed by 3 weeks
off. 2-4 cycles are necessary
§ Topical lubricants
19.
After 1 cycleof 5- FU
Vision improved to 6/24 in the R/E
21.
§ OSSN isthe most common tumor of the ocular surface
§ It encompasses a wide and varied spectrum of diseases involving abnormal growth
of dysplastic squamous epithelial cells on the surface of the eye.
§ The term OSSN was given by Lee and Hirst in 1995
§ Worldwide incidence is 0.02 to 3.5 cases per 100,000 people
§ Males> Females
§ More common in the elderly age group (6th to 7th decade)
§ The incidence is higher in countries located close to the equator
22.
§ Excessive exposureto UV radiation
§ Heavy cigarette smoking
§ Immunosuppressive conditions: HIV infection (AIDS), chronic use of
immunosuppressants, post-organ transplantation
§ Xeroderma pigmentosum
§ Ocular surface injury
§ Exposure to chemicals
§ Vit A deficiency
§ HPV infection
23.
§ SYMPTOMS: Rednessand ocular irritation
§ SIGNS:
§ typically presents as a fleshy sessile lesion adjacent to the limbus in the interpalpebral
region involving the cornea and/ or bulbar conjunctiva
(Mutations in the limbal stem cells might be the reason for the limbal location)
§ The lesion may be
§ Flat/ elevated
§ Localised/ diffuse
§ Varying degrees of surface keratin
§ Feeder vessels and or intrinsic vascularity
§ Pearly grey to pinkish red in colour with varying patterns of pigmentation
24.
§ Based onthe number of clock hours of limbal involvement or maximum basal
diameter, the tumour can be classified as
§ Small (<5mm basal diameter)
§ Large (6- 15mm basal diameter or >3-6 clock hours)
§ Diffuse (>15mm basal diameter or >6 clock hour)
§ Multifocal OSSN- is reported in 4-26% of cases. It is described by the presence of 2
tumours separated by a minimum of 5mm distance in between them.
§ Aggressive variants of SCC are
§ Spindle cell variant
§ Adenoid variant
§ Mucoepidermoid variant
26.
1. Dysplasia
§ Lesionsexhibit varying degrees of cellular atypia that may involve varying thickness of the
epithelium and show epithelial cell disorganization and loss of normal cell polarity
§ Classified into
§ Mild dysplasia (atypical cells occupying the lower 1/3rd of the epithelium)
§ Moderate dysplasia (extending to the middle 1/3rd of the epithelium)
§ severe dysplasia (full thickness)
2. Carcinoma in situ (CIN)
§ CIN lesions contain a mixture of spindle cells and epidermoid cells.
§ There is disorganization of the cells, abnormal polarity, and an increase in the nuclear -to-
cytoplasmic ratio. Mitotic figures are sometimes seen.
§ On pathology, there is a characteristic sharp demarcation line between normal and abnormal
epithelium
3. Invasive squamous cell carcinoma (SCC)
§ The basement membrane of the epithelium is breached and the subepithelial tissue of the
conjunctiva is invaded
§ Show surface keratinisation with cellular pleomorphism, hyperplastic and hyperchromatic cells,
dyskeratosis, keratin pearls, loss of cellular cohesiveness and atypical mitotic figures.
§ Rose Bengalstain- stains the dead, degenerating and devitalized tissue
§ Fluorescein stain- delineates the tumour margins especially on the corneal
surface
§ Anterior segment optical coherence tomography (AS-OCT)
§ Features of OSSN on ASOCT are
§ Thickened epithelium
§ Hypereflective epithelium
§ Abrupt transition from normal to abnormal epithelium
§ Back shadowing
29.
§ Exfoliative cytology
§helps in the diagnosis of neoplastic epithelial cells as they have poor cell adherence and
tend to desquamate. It uses a small cytobrush to obtain the sample.
§ Impression cytology
§ Simple, inexpensive and non-invasive method
§ Uses cellulose acetate filter paper sheets
§ Confocal microscopy
§ helpful in guiding treatment since it is able to reveal cellular details
§ Indicates hyperreflective pleomorphic dysplastic cells with increased N: C ratio, well
border between neoplastic and normal epithelium and loss of sub basal corneal nerves
§ Characteristic “starry sky” appearance
§ Ultrasound biomicroscopy
§ Helps in determining the thickness of the lesion and the extent of introcular invasion
when present
§ Orbital imaging
§ By CT or MRI in cases with forniceal involvement to rule out any orbital extension
31.
The different modalitiesavailable for OSSN treatment include:
§ Wide surgical excision
§ Cryotherapy
§ Chemotherapy
§ Immunotherapy
§ Antiviral medications
§ Topical or sub- conj anti- VEGF
§ Radiotherapy
§ Photodynamic therapy
§ Extended enucleation
§ Orbital exenteration
33.
Indications:
§ >2 quadrantsof conjunctival involvement
§ >180 degrees of limbal involvement (>3 or 4 clock hours)
§ Clear corneal extension encroaching the pupillary axis
§ Positive margin after excision
§ Patient not fit for surgery
34.
4 times aday (4 days on
and 3 days off) for 4
weeks followed by 3
weeks drug holiday is
one cycle of treatment
4 times a day for 1 week
followed by 3 weeks off is
1 cycle
Topical dose is 4 times a
day